AR065107A1 - Compuestos inhibidores de dopamina-beta-hidroxilasa - Google Patents

Compuestos inhibidores de dopamina-beta-hidroxilasa

Info

Publication number
AR065107A1
AR065107A1 ARP080100395A ARP080100395A AR065107A1 AR 065107 A1 AR065107 A1 AR 065107A1 AR P080100395 A ARP080100395 A AR P080100395A AR P080100395 A ARP080100395 A AR P080100395A AR 065107 A1 AR065107 A1 AR 065107A1
Authority
AR
Argentina
Prior art keywords
dopamine
beta
inhibiting compounds
hydroxylase inhibiting
hydroxylase
Prior art date
Application number
ARP080100395A
Other languages
English (en)
Spanish (es)
Original Assignee
Portevin Bernard
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0701969A external-priority patent/GB0701969D0/en
Priority claimed from GB0701968A external-priority patent/GB0701968D0/en
Application filed by Portevin Bernard filed Critical Portevin Bernard
Publication of AR065107A1 publication Critical patent/AR065107A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
ARP080100395A 2007-02-01 2008-01-31 Compuestos inhibidores de dopamina-beta-hidroxilasa AR065107A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0701969A GB0701969D0 (en) 2007-02-01 2007-02-01 Compounds
GB0701968A GB0701968D0 (en) 2007-02-01 2007-02-01 Compounds

Publications (1)

Publication Number Publication Date
AR065107A1 true AR065107A1 (es) 2009-05-13

Family

ID=39272441

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080100395A AR065107A1 (es) 2007-02-01 2008-01-31 Compuestos inhibidores de dopamina-beta-hidroxilasa

Country Status (5)

Country Link
US (1) US20100093817A1 (enExample)
EP (1) EP2121668A2 (enExample)
JP (1) JP2010517998A (enExample)
AR (1) AR065107A1 (enExample)
WO (1) WO2008094054A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0701965D0 (en) * 2007-02-01 2007-03-14 Portela & Ca Sa Process
US10072039B2 (en) 2013-07-25 2018-09-11 Scinopharm Taiwan, Ltd. Process for the production of Fondaparinux sodium
KR20160036606A (ko) * 2013-07-25 2016-04-04 시노팜 타이완 리미티드 폰다파리눅스 소듐의 제조 방법
EP3527578A4 (en) * 2016-10-14 2020-07-15 Bonac Corporation NOVEL GLYCOSIDE COMPOUND AND PROCESS FOR PRODUCING THE SAME
CN111333528B (zh) * 2020-04-10 2022-10-21 苏州爱玛特生物科技有限公司 一种多构型o-苯基-丝氨酸类化合物的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995029165A2 (en) * 1994-04-26 1995-11-02 Syntex (U.S.A.) Inc. Benzocycloalkylaz0lethione derivatives as dopamin beta-hydroxylase inhibitors
US7125904B2 (en) * 2002-10-11 2006-10-24 Portela & C.A., S.A. Peripherally-selective inhibitors of dopamine-β-hydroxylase and method of their preparation

Also Published As

Publication number Publication date
WO2008094054A2 (en) 2008-08-07
JP2010517998A (ja) 2010-05-27
WO2008094054A3 (en) 2008-09-18
EP2121668A2 (en) 2009-11-25
US20100093817A1 (en) 2010-04-15

Similar Documents

Publication Publication Date Title
ES2634490T3 (es) Derivados de ácido napht-2-ylacetico para tratar el sida
UY31084A1 (es) Compuestos de azaindol para la inhibicion de b-secretasa
CR20110634A (es) Inhibidores de fosfoinositida 3 cinasa y/ u objetivo mamifero de rapamicina
UY32490A (es) Inhibidores de beta-secretasa
TW200736248A (en) Compounds for the treatment of inflammatory disorders
UY31083A1 (es) Derivados de sulfoximinas para la inhibicion de b-secretasa
AR112532A2 (es) Compuestos de tetraciclina sustituidos con flúor en c7
AR091857A1 (es) INHIBIDORES DE CISTATIONIN-g-LIASA (CSE)
CR20140413A (es) Inhibidores de serina/treonina cinasa
TW200637866A (en) Amino-imidazolones for the inhibition of β-secretase
JO2892B1 (en) CYP inhibitors 17
MX2013007336A (es) Compuestos de bi-heteroarilo como inhibidores de vps34.
DOP2006000170A (es) Nuevos derivados de espirocromanona
CR20150078A (es) Análogos de piridazina 1,4-disustituida y métodos para el tratamiento de condiciones relacionadas con la deficiencia de smn
CR11510A (es) Uso de un inhibidor de la gamma-secretasa para tratamiento del cancer
CO6480931A2 (es) Sulfonamidas heterocíclicas, usos y composiciones farmacéuticas de las mismas.
CO6531458A2 (es) Nuevos compuestos de espiropiperidina
GEP20146131B (en) Carbazole compounds and therapeutic uses thereof
EA201001524A1 (ru) Ингибиторы дезацетилазы в, основанные на гидроксамате
ECSP12011930A (es) Nuevos compuestos de espiropiperidina
ECSP13012755A (es) Composiciones farmacéuticas que contienen un inhibidor de dgat1
ATE554084T1 (de) N-hydroxyacrylamidverbindungen
EA201491292A1 (ru) Составы (+)-2-[1-(3-этокси-4-метоксифенил)-2-метансульфонилэтил]-4-ацетиламиноизоиндолин-1,3-диона
MX347476B (es) Compuestos de ácido dimetil-benzoico.
UY37837A (es) Nuevos compuestos heterocíclicos como inhibidores de cdk8/19

Legal Events

Date Code Title Description
FB Suspension of granting procedure